Skip to main navigation Skip to search Skip to main content

Colchicine use in children and adolescents with familial Mediterranean fever: Literature review and consensus statement

  • Tilmann Kallinich
  • , Dieter Haffner
  • , Tim Niehues
  • , Kristina Huss
  • , Elke Lainka
  • , Ulrich Neudorf
  • , Christof Schaefer
  • , Silvia Stojanov
  • , Christian Timmann
  • , Rolf Keitzer
  • , Huri Ozdogan
  • , Seza Ozen
  • Charité – Universitätsmedizin Berlin
  • University of Rostock
  • Heinrich Heine University Düsseldorf
  • Ludwig Maximilian University of Munich
  • University of Duisburg-Essen
  • Berliner Betrieb für Zentrale Gesundheitliche Aufgaben
  • National Institutes of Health
  • Bernhard Nocht Institute for Tropical Medicine
  • Istanbul University

Research output: Contribution to journalReview articlepeer-review

232 Citations (Scopus)

Abstract

The daily application of colchicine is the standard therapy for prophylaxis of attacks and amyloid deposition in familial Mediterranean fever. However, because of many issues (eg, dosage, time of introduction, etc), no standardized treatment recommendations have been established. In this work we review the available literature on colchicine use with respect to its indication, efficacy, mode of application, and safety in children and adolescents with familial Mediterranean fever. On the basis of this analysis, a consensus statement on the application of colchicine in children and adolescents with familial Mediterranean fever was developed by caregivers from Germany, Austria, and Turkey.

Original languageEnglish
Pages (from-to)e474-e483
JournalPediatrics
Volume119
Issue number2
DOIs
Publication statusPublished - Feb 2007

Keywords

  • Colchicine
  • Evidence-based guidelines
  • Familial Mediterranean fever
  • Treatment

Fingerprint

Dive into the research topics of 'Colchicine use in children and adolescents with familial Mediterranean fever: Literature review and consensus statement'. Together they form a unique fingerprint.

Cite this